A similar behavior in BC, by decreased levels of ADPN in obesity, would support the inhibitory effect of ADPN in ER− or low ER expression postmenopausal cases, in which AR signaling plays a clearer role as a tumor promoter. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.